Study of Tryptase Activity and Selenium Concentration in Cardiovascular And Diabetic Patients
Article Sidebar
Main Article Content
Abstract
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality among patients with diabetes mellitus (DM). DM can lead to multiple cardiovascular complications, including coronary artery disease (CAD), cardiac hypertrophy, and heart failure (HF). HF represents one of the most common causes of death in patients with DM and results from DM-induced CAD and diabetic cardiomyopathy. selenium concentration and tryptase activity were obtained from 52 samples: 30 sample with cardiovascular and diabetic patients, and 22 normal healthy. A highly significant decrease (p<0.0001) in the levels of selenium, and a significant increase (p<0.05) in the levels of tryptase in serum of patients with cardiovascular and diabetic patients compared with normal individuals. selenium concentration was affected by cardiovascular and diabetic patients and tryptase has higher diagnostic validity values in the current study.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
1. Mohammed F Jabir . Alan Begg, Coronary Heart Disease Prevention For Diabetic Patients In Primary Care – An Audit of Clinical Practice. Scottish Universities Medical Journal, Dundee, SUMJ,2012.
2. Haffner, S.M.; Lehto, S.; Ronnemaa, T.; Pyorala, K.; Laakso, M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 1998, 339, 229–234.
3. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414, 813–820.
4. Braunwald, E. Biomarkers in heart failure. N. Engl. J. Med. 2008, 358, 2148–2159.
5. Haffner, S.M. The metabolic syndrome: Inflammation, diabetes mellitus, and cardiovascular disease. Am. J. Cardiol. 2006, 97, 5.
6. Khullar, M.; Al-Shudiefat, A.A.; Ludke, A.; Binepal, G.; Singal, P.K. Oxidative stress: A key contributor to diabetic cardiomyopathy. Can. J. Physiol. Pharmacol. 2010, 88, 233–240.
7. Grundy, S. M., et al. ―Definition of metabolic syndrome: report of the National heart, Lung and Blood Institute/ American Heart Association conference on scientific issues related to definition.‖ Circulation 109 (2004) 433-438.
8. Deshpande, A D, M Harris-Hayes, and M Schootman. "Epidemiology of Diabetes and Diabetes- Related Complication." Physical Therapy 88.11 (2008): 1254-1266.
9. U Alehagen, P Johansson, M Björnstedt, A Rosén, C Post and J Aaseth, Relatively high mortality risk in elderly Swedish subjects with low selenium status, European Journal of Clinical Nutrition (2016) 70, 91–96.
10. Mena Yahya, Mufeed Ewadh, Monem ALshok , Cardiovascular Diseases Correlation with Trace Elements in Hilla City, Advances in Life Science and Technology, Vol. 17, 2014.
11. Bonadonna, C Lombardo, R Zanotti, Mastocytosis and Allergic Diseases, J Investig Allergol Clin Immunol 2014; Vol. 24(5): 288-297.
12. Marı´a Moreno, Josep Puig, Marta Serrano, Jose´ Marı´a Moreno-Navarrete, Francisco Ortega ,Wifredo Ricart, Jose Manuel Fernandez-Real, Circulating Tryptase as a Marker for Subclinical Atherosclerosis in Obese Subjects, PLOS ONE, 2014 |Volume 9| Issue 5.
13. Baker JO, Reinhold J, Redwood S, Marber MS. Troponins: redefining their limits. Heart, 2011; 97(6): 477-452.111.
14. Human tryptase ELISA Kit, CUSABIO BIOTECH CO., Ltd., Catalog Number. CSB -E09012h.
15. Weatherby D. and S.Feruson (2004), Blood Chemistry and CBC Analysis, 1st editon, Weatherby and Associates, UK.
16. Marczenko Z. (1976) Spectrophotometric Determination of Elements, 1st edition , Ellis
Horwood, Poland. Journal of Pharmaceutical and Clinical Research; 4(4): 73-76.
17. Weatherby R. (2000) , "Reference Guide to Blood Chemistry Analysis " , 2 nd edition , Bear Mountain publishing , US.
18. Mojtaba Beheshti Tabar, Determination of Serum Selenium in Patients with Type II Diabetes Mellitus, Middle-East Journal of Scientific Research 12 (4): 433-435, 2012.
19. Ashley N. Ogawa-Wong, Marla J. Berry and Lucia A. Seale, Selenium and Metabolic Disorders: An Emphasis on Type 2 Diabetes Risk, Nutrients 2016, 8, 80.
20. I K Akhuemokhan, A Eregie, and O A Fasanmade, Diabetes prevention and management the role of trace minerals, African Journal of Diabetes Medicine, Vol 21 No 2 November 2013.,37-41.
21. Mohammed Kabir Ahmed, Mohammed Aliyu , Tanko Yusuf, Musa Kabir Yusuf, Ameliorative effect of selenium yeast on blood glucose level in streptozotocin induced diabetes in wistar rats, Cell Biology 2015; 3(1): 14-18.
22. S. Boussekine, N. Bouzerna, R. Rouabhi, Protective effect of selenium supplementation on antioxidant defence and cardiovascular diseases in alloxan diabetic rats, International Journal of Biosciences IJB ., Vol. 4, No. 5, p. 1-10, 2014.
23. .Jacob Joseph and Joseph Loscalzo, Selenistasis: Epistatic Effects of Selenium on Cardiovascular Phenotype, Nutrients 2013, 5, 340-358.
24. Arroyo, M.; Laguardia, S.P.; Bhattacharya, S.K.; Nelson, M.D.; Johnson, P.L.; Carbone, L.D.; Newman, K.P.; Weber, K.T. Micronutrients in African - Americans with decompensated and compensated heart failure. Transl. Res. 2006, 148, 301–308.
25. Ana Stevanovic, Mark Coburn, Ares Menon, Rolf Rossaint, Daren Heyland , Gereon Schalte et al., The Importance of Intraoperative Selenium Blood Levels on Organ Dysfunction in Patients Undergoing Off-Pump Cardiac Surgery: A Randomised Controlled Trial, PLOS ONE, August 2014 | Volume 9 | Issue 8.
26. P. Savitha, Role of Selenium, J. Pharm. Sci. & Res. Vol. 6(1), 2014, 56 – 59.
27. Suzanne M. Cunningham , Heart Failure: Heart Disease and Heart Failure, Daniel J. Hall ,2011 .
28. Rajpathak S, Rimm E, Morris JS, Hu F (2005) Toenail selenium and cardiovascular disease in men with diabetes. J Am Coll Nutr 24:250–256.
29. Wang Z, Zhang H, Shen XH, Jin KL, Ye GF, et al. (2011) Immunoglobulin E and mast cell proteases are potential risk factors of human pre-diabetes and diabetes mellitus. PLoS One 6:e28962.
30. Wang Z, Zhang H, Shen XH, Jin KL, Ye GF, et al. (2013) Immunoglobulin E and mast cell proteases are potential risk factors of impaired fasting glucose and impaired glucose tolerance in humans. Ann Med 45:220–9.
31. Shi, Michael A., and Guo - Ping Shi. 2012. Different roles of mast cells in obesity and diabetes: Lessons from experimental animals and humans. Frontiers in Immunology 3:7.
32. Marı´a Moreno , Josep Puig , Marta Serrano, Jose´ Marı´a Moreno-Navarrete, Francisco Ortega, Wifredo Ricart, Jose Manuel Fernandez - Real, Circulating Tryptase as a Marker for Subclinical Atherosclerosis in Obese Subjects, PLOS ONE, May 2014 | Volume 9 | Issue 5.
33. Efthymios N. Deliargyris, Bharathi Upadhya, David C. Sane, Gregory J. Dehmerc, Joseph Pye, Sidney C. Smith Jr., William S. Boucher, Theoharis C. Theoharides,, Mast cell tryptase: a new biomarker in patients with stable coronary artery disease, Atherosclerosis 178 (2005) 381–386.
34. Bot I, Biessen EA (2011) Mast cells in atherosclerosis. Thromb Haemost : 106:820–826.
35. Patella V, Marino I, Arbustini E, et al. Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 1998;97:971.
36. Frangogiannis NG, Shimoni S, Chang SM, et al. Evidence for an active inflammatory process in the hibernating human myocardium. Am J Pathol 2002; 160:1425–33.
37. Pastorello E.A., Morici N., Farioli L., Di Biase M., Losappio L.M., Nichelatti M., Lupica L., Schroeder J.W., Stafylaraki C., Klugmann S, Serum Tryptase: A New Biomarker in Patients with Acute Coronary Syndrome?, Int Arch Allergy Immunol 2014;164:97-105.